first large study of glp 1 receptor agonists during pregnancy Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Continuing Glucagon-Like Peptide-1 Receptor Agonists
Description
There was a dose-response relationship between liraglutide and increased nitric oxide generation in
Berger J
Another study indicates that starting treatment with a lower dose and gradually increasing it helped reduce the incidence of gastrointestinal adverse events [64]
Multiple other molecules (including combinations of entero-pancreatic hormones and oral GLP-1 RA) are in late phase clinical trials as potential obesity treatments, leading to WL that approaches the efficacy of bariatric surgery [101]
Kushner, R
However, they arent appropriate for everyone, and insurance coverage isnt guaranteed
